Polyphagia, polydipsia, polyuria. At age 19 as a junior in college, I didn’t know that I was presenting with three very classic symptoms of type 1 dia…
The impact of COVID-19 has touched all our lives in profound ways. From the start I’ve been particularly focused on the science and health impacts — b…
This summer, Vertex hosted an engrossing conversation between Reshma Kewalramani, Vertex’s CEO and President, and Gerald Chertavian, Founder and CEO o…
At Vertex, we think about pain, especially severe pain, as a major societal burden and an area with huge unmet need. Severe pain affects millions of p…
Vertex is proud to announce this year’s Vertex Science Leaders Scholars — Chiruza Muhimuzi and Mykayla Smith. They will both receive a four-year, full…
As Vertex advances our cell and genetic therapy programs, we are continually inspired and motivated by the patients and communities we aim to serve. B…
I just had the opportunity to attend this year’s American Society of Gene & Cell Therapy (ASGCT) annual meeting — one of my favorite conferences o…
Unprecedented. It’s a term we’ve all heard often throughout the COVID-19 pandemic, but it really sums up what I know the past year has been like for t…
When we started our journey in cystic fibrosis (CF) more than 20 years ago, the idea of fixing the broken protein that causes the disease seemed more …
This year marks the 100-year anniversary of the discovery of insulin as a treatment for people with type 1 diabetes (T1D), and over the past century, …
As a CFO, there are many things I love about April — the return of warm weather and the start of golf season in Boston, and of course, the opportunity…
At Vertex Pharmaceuticals, we recognize Rare Disease Week and Rare Disease Day® at the end of February every year, but our commitment to patients is o…
2020 was an unimaginable year, and I’m extremely proud of the impact the Vertex Foundation continues to make. Faced with unprecedented challenges, we …
At Vertex, we think about pain, especially severe pain, as a major societal burden and an area with huge unmet need. Severe pain affects millions of p…
Challenge brings opportunity, and our Employee Experience team has embraced both the challenges and opportunities of onboarding more than 700 new empl…
At Vertex we’re focused on developing potentially transformative new therapies for diseases where we have a deep understanding of the underlying causa…
Physician investigators are uniquely qualified to leverage both their clinical and their scientific training to make an impact in how we care for pati…
Every year in November, Vertex joins the alpha-1 antitrypsin deficiency community in recognizing AATD Awareness Month. To help raise awareness about t…
In 2010, scientists showed that higher rates of two severe kidney diseases in African Americans could be attributed to variants in a gene called APOL1…
Natural disasters impact hundreds of millions of people every year and claim the lives of nearly 100,000 people annually around the world. This create…
One of our core values at Vertex is an Uncompromising Commitment to Patients. As our Chief Patient Officer, what I love about our values is that …
At Vertex, we believe the most important medicines are those that have transformative impact for patients. And while drug discovery and development ar…
Every summer, there’s a special buzz of energy in our Vertex Learning Labs that goes beyond what you might find during the daily class visits we host …
David Altshuler, M.D., Ph.D. & Bastiano Sanna, Ph.D. | June 12, 2020
At Vertex, our strategy is to invest in scientific innovation to make transformative medicines for serious diseases. We are advancing that strategy wi…
The Vertex Foundation Scholarship helps people with cystic fibrosis (CF) and their immediate family members pursue two-year, four-year or graduate deg…
We live in a world that relies on data. Data is used to inform everything from our hiring practices, to our building and lab designs, our clinical dev…
Partnering with our communities to make the places where we live and work stronger is a priority for the Vertex Foundation, especially during these un…
One of the reasons I joined Vertex back in 2007 was the fierce passion I felt from every employee to pursue science in the name of transforming lives …
The Milken Institute released new essays in their #PowerofIdeas series on the unique challenges, opportunities for growth and collaborative responses …
At Vertex, we have some of the industry’s best and brightest minds working together to bring transformative new medicines to people living with seriou…
We are all facing serious challenges as a result of the rapidly evolving COVID-19 pandemic. We also know that a respiratory illness can be especially …
I love the work we do at Vertex to get kids excited about science. Whether it’s a visit to our Learning Lab for a hands-on experiment or a placement i…
On the last day of February, we honor Rare Disease Day, an annual awareness day to elevate public understanding of rare diseases and call attention to…
We created the Vertex Foundation as a long-term source of charitable giving to make a difference in the lives of people living with serious diseases a…
At Vertex, we bring the best and brightest minds together to strike at the core of serious diseases. Everyone who is hired — an intern, our leaders an…
I’m incredibly proud to share that Vertex has received a perfect score on the Human Rights Campaign’s 2020 Corporate Equality Index (CEI), a national …
Whether you’re a parent of a child newly diagnosed with cystic fibrosis (CF) or a college student learning how to manage the disease while living away…
When I moved to Vertex in 2015 from the Broad Institute, I quickly recognized a gap in the biomedical ecosystem: there are precious few opportunities …
Over the last 30 years, drugs and devices stemming from important scientific research have revolutionized the treatment of serious diseases, so much s…
Helping others is at the heart of what we do here at Vertex. Whether it’s developing transformative medicines to help those with serious diseases or e…
Today we announced the first data from our CRISPR gene-editing program for sickle cell disease and transfusion-dependent beta thalassemia. These early…
Volunteering is part of our culture, but our annual Day of Service is one of the ways we demonstrate our commitment to our communities, get to know ea…
When I joined Vertex in 2018, I knew I was embarking on an exciting journey during a pivotal time in the company’s history. Vertex has spent 30 years …
On the 50th anniversary of Earth Day and in the spirit of this year’s theme of Climate Action, we wanted to share some of the actions we’ve taken at V…
Science is at the heart of Vertex and Vertex scientists love the opportunity to welcome visitors to our state-of-the art research labs in Boston, San …
I remember first learning about CRISPR years ago and thinking, “this technology could really work.” At the time, I didn’t realize that I would get to …
At Vertex, we’re dedicated to creating transformative medicines that treat the underlying cause of serious diseases — like Duchenne muscular dystrophy…
The kidneys. These two bean-shaped organs located on either side of the spine are the source of my life’s work. Because March is National Kidney Month…
Vertex is in the middle of a hiring boom. As we expand into new disease areas and new modalities with an accelerating pipeline of potentially transfor…
